RENX

RENALYTIX AI PLC ORD 0.25P (REG S)

TitleTime
Second Price Monitoring ExtnWed 20/05/20 | 11:06
Price Monitoring ExtensionWed 20/05/20 | 11:00
JV for COVID-19 antibody test scaled productionWed 20/05/20 | 07:00
Proposed dual-listing on NasdaqMon 18/05/20 | 07:00
Result of General MeetingFri 15/05/20 | 13:02
Removal of US Securities Law RestrictionsTue 05/05/20 | 10:55
Update re. potential demerger of FractalDxTue 28/04/20 | 07:00
KidneyIntelX used in Mount Sinai COVID-19 studyMon 20/04/20 | 07:00
Provider network agreement for KidneyIntelX?Wed 15/04/20 | 07:00
Medicare provider numberWed 01/04/20 | 07:00
Holding(s) in CompanyFri 27/03/20 | 10:32
Half-year ReportTue 03/03/20 | 07:00
Notice of ResultsWed 26/02/20 | 07:00
New commercial testing facility opens in UtahWed 08/01/20 | 07:00
Medicare sets US national price for KidneyIntelXTue 03/12/19 | 07:00
Grant of OptionsThu 21/11/19 | 07:00
Partnership with CDPHP on KidneyIntelXThu 17/10/19 | 07:00
Board appointmentMon 14/10/19 | 07:00
US CPT® reimbursement code effectiveTue 01/10/19 | 07:00
Result of AGMMon 30/09/19 | 16:37
Update on non-executive director appointmentMon 30/09/19 | 08:00
Preliminary Medicare Pricing DeterminationMon 30/09/19 | 07:00
Posting of Annual Report & Accounts &Notice of AGMFri 06/09/19 | 16:00
Final ResultsTue 03/09/19 | 07:00
Notice of ResultsTue 20/08/19 | 07:00
Expansion of Chronic Kidney Disease Advisory BoardTue 06/08/19 | 07:00
Total Voting RightsWed 31/07/19 | 16:30
Result of Placing & Total Voting RightsTue 23/07/19 | 18:23
Proposed Placing to raise £12.0m (c.US$15.0m)Tue 23/07/19 | 07:01
Positive Interim Results for Validation StudyTue 09/07/19 | 07:00
US CPT® Code Granted for KidneyIntelX(TM)Mon 01/07/19 | 07:00
Second Price Monitoring ExtnThu 02/05/19 | 14:05
Price Monitoring ExtensionThu 02/05/19 | 14:00
FDA grants Breakthrough Device designationThu 02/05/19 | 07:00
Acquisition of further interest in Renalytix AIFri 26/04/19 | 18:20
Director/PDMR ShareholdingFri 26/04/19 | 17:42
Holding(s) in CompanyTue 02/04/19 | 12:55
Publication of confirmation study resultsMon 01/04/19 | 07:00
Half-year ReportMon 25/03/19 | 07:00
Appointment of Nomad and Joint BrokerThu 14/02/19 | 07:00
Joint venture partnership agreement with AKESOgenWed 13/02/19 | 07:00
Initiates Clinical Validation StudyWed 23/01/19 | 07:00
Clarification re. lock-up restrictionsMon 21/01/19 | 07:00
Exercise of Option for Exclusive LicenseWed 02/01/19 | 07:00
Director/PDMR ShareholdingThu 20/12/18 | 17:20
Planned appointment of joint broker & of NOMADThu 20/12/18 | 07:01
Director DealingWed 19/12/18 | 18:28
Holding(s) in CompanyMon 17/12/18 | 13:30
Holding(s) in CompanyFri 09/11/18 | 10:30
Holding(s) in CompanyThu 08/11/18 | 16:50
Director/PDMR ShareholdingThu 08/11/18 | 07:00
RENX Admission to AIM and First Day of DealingsTue 06/11/18 | 07:00